Conference call and webcast to begin after markets close at 2:00 p.m. PT (5:00 p.m. ET)
IRVINE, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-
and-Low-Perfusion pulse oximetry, today announced it will release third
quarter financial results for the period ended September 27, 2008 after the
market closes on Monday, October 27, 2008.
A conference call to review the results will begin at 2:00 p.m. PT
(5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and Chief
Executive Officer, and Mark P. de Raad, Executive Vice President and Chief
Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the Company's corporate web site at www.masimo.com.
The dial-in numbers are (800) 399-7902 for domestic callers and
+1 (706) 634-0949 for international callers. The reservation number for both
dial-in numbers is 68032269. After the live webcast, the call will remain
available on Masimo's website through November 27, 2008. In addition, a
telephonic replay of the call will be available until November 9, 2008. The
replay dial-in numbers are (800) 642-1687 for domestic callers and +1 (706)
645-9291 for international callers. Please use reservation code 68032269.
About Masimo
Masimo (NASDAQ: MASI) develops innovative monitoring technologies that
significantly improve patient care -- helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse
oximetry, known as Masimo SET, which virtually eliminated false alarms and
increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most reliable SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral perfusion. In
2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough
noninvasive blood constituent monitoring platform that can measure many blood
constituents that previously required invasive procedures. Rainbow SET
continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen
content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and
PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion
index (PI), allowing early detection and treatment of potentially
life-threatening conditions. Founded in 1989, Masimo has the mission of
"Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications." Additional information about
Masimo and its products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse CO-Oximeter
are trademarks or registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation